Beta
Dolutegravir
medication Under reviewAn integrase strand transfer inhibitor used as part of antiretroviral therapy to manage HIV infection.
Research summary
Scientific evidence on dolutegravir primarily comes from clinical trials and observational studies in HIV patients, demonstrating high efficacy and generally good tolerability with low discontinuation rates. Common adverse effects include neuropsychiatric symptoms like headache and insomnia, though these are manageable for most individuals. No studies were identified specifically in healthy human subjects without HIV, limiting direct applicability as a general supplement.
Reported Side Effects
No reports yet
Be the first to report this effect and help the community.
Add Dolutegravir to your stack to report effects
Dolutegravir: Pros and Cons (Are There Any Cons?)
Brian R. Wood, MD
No reports yet
Be the first to report this effect and help the community.
Add Dolutegravir to your stack to report effects
Dolutegravir: Pros and Cons (Are There Any Cons?)
Brian R. Wood, MD
Research (1 study)
Dolutegravir: Pros and Cons (Are There Any Cons?)
Brian R. Wood, MD
Community updates
No updates yet for this supplement.
Be the first to share your experience!